raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:221

Dermatomyositis

Synonyms: Adult dermatomyositis

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adult, Elderly
Status
active

A rare idiopathic inflammatory myopathy (IIM) characterized by evocative skin lesions, muscle involvement with symmetrical proximal muscle weakness, and specific histological features. The clinical subtypes are defined by the presence of myositis-specific antibodies (anti-Mi2, anti-NXP2, anti-TIF1-γ, anti-MDA5, or anti-SAE antibodies) and are associated with specific clinical phenotypes and prognosis.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enDermatomyositisAdult dermatomyositis
frDermatomyositeDermatomyosite de l'adulte
deDermatomyositisDM · Dermatomyositis, adulte
esDermatomiositisDermatomiositis del adulto
itDermatomiositeDM
nlDermatomyositisVolwassen dermatomyositis
ptDermatomiosite
plZapalenie skórno-mięśnioweDM
csDermatomyozitidaDM
ukДерматоміозитДерматоміозит у дорослих
zh皮肌炎成人皮肌炎
trDermatomiyozitErişkin dermatomiyozit

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10M33.0NTBTattributedvalidated
ICD-10M33.1NTBTattributedvalidated
ICD-114A41.00Especificvalidated
MONDO0016367Evalidated
MeSHD003882Evalidated
UMLSC0011633Evalidated
GARD6263Evalidated
MedDRA10012503Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

Children (3):

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

14 records
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.1 / 100 000AustraliaValue and classValidated23981756[PMID]
Point prevalence1-9 / 100 0001.97 / 100 000AustraliaValue and classValidated23981756[PMID]
Annual incidence1-9 / 1 000 0000.32 / 100 000ArgentinaValue and classValidated23965482[PMID]
Point prevalence1-5 / 10 00010.2 / 100 000ArgentinaValue and classValidated23965482[PMID]
Annual incidence1-9 / 1 000 0000.49 / 100 000SpainValue and classValidated18053482[PMID]
Annual incidence1-9 / 100 0001.1 / 100 000United StatesValue and classValidated34549549[PMID]
Point prevalence1-5 / 10 00013 / 100 000United StatesValue and classValidated34549549[PMID]
Point prevalence1-9 / 100 0004.9172 / 100 000NorwayValue and classValidated24695011[PMID]_ORPHANET
Annual incidence1-9 / 1 000 0000.32 / 100 000SwedenValue and classValidated28160487[PMID]
Point prevalence1-9 / 100 0003.8 / 100 000SwedenValue and classValidated28160487[PMID]
Annual incidence1-9 / 100 0003.5 / 100 000GermanyValue and classValidated36581896[PMID]
Point prevalence1-5 / 10 00011.3 / 100 000GermanyValue and classValidated36581896[PMID]
Annual incidence1-9 / 100 0000.9704 / 100 000WorldwideValue and classValidated36581896[PMID]_ORPHANET
Point prevalence1-9 / 100 0007.5312 / 100 000WorldwideValue and classValidated36581896[PMID]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

76 annotations · validated 2026-05-15
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0002960Autoimmunity
HP:0000969Edema
HP:0010783Erythema
HP:0009071Inflammatory myopathy
HP:0003325Limb-girdle muscle weaknessDiagnostic criterion
HP:0003326Myalgia
HP:0100539Periorbital edema
HP:0003701Proximal muscle weaknessDiagnostic criterion
Frequent (79-30%)
HP:0006530Abnormal pulmonary interstitial morphology
HP:0001063Acrocyanosis
HP:0034140Anti-SUMO-activating enzyme subunit 1 antibody positivity
HP:0034141Anti-SUMO-activating enzyme subunit 2 antibody positivity
HP:0002829Arthralgia
HP:0001369Arthritis
HP:0002207Diffuse reticular or finely nodular infiltrations
HP:0003458EMG: myopathic abnormalitiesDiagnostic criterion
HP:0012544Elevated circulating aldolase concentrationDiagnostic criterion
HP:0003236Elevated circulating creatine kinase concentrationDiagnostic criterion
HP:0002910Elevated circulating hepatic transaminase concentrationDiagnostic criterion
HP:0001041Facial erythema
HP:0012378Fatigue
HP:0025508Gottron's papulesPathognomonic sign
HP:0040324Heliotrope rashPathognomonic sign
HP:0001252Hypotonia
HP:0025435Increased circulating lactate dehydrogenase concentrationDiagnostic criterion
HP:0100614MyositisDiagnostic criterion
HP:0200034Papule
HP:0033425Periungual erythema
HP:0000989Pruritus
HP:0002206Pulmonary fibrosis
HP:0002093Respiratory insufficiency
HP:0002747Respiratory insufficiency due to muscle weaknessDiagnostic criterion
HP:0025535Shawl sign
HP:0000988Skin rashDiagnostic criterion
HP:0200042Skin ulcer
HP:0001824Weight loss
Occasional (29-5%)
HP:0001596Alopecia
HP:0033033Anti-MDA5 antibody positivity
HP:0033554Anti-Mi2 antibody positivity
HP:0034139Anti-SUMO-activating enzyme antibody positivity
HP:0034152Anti-histidyl tRNA synthetase antibody positivity
HP:0034142Anti-nuclear matrix protein-2 antibody positivity
HP:0034105Anti-transcription intermediary factor-1gamma antibody positivity
HP:0011675Arrhythmia
HP:0025520Calcinosis cutis
HP:0000992Cutaneous photosensitivity
HP:0002015DysphagiaDiagnostic criterion
HP:0001618Dysphonia
HP:0003457EMG abnormalityDiagnostic criterion
HP:0000282Facial edema
HP:0001945Fever
HP:0100758Gangrene
HP:0430033Gottron signPathognomonic sign
HP:6000006Holster sign
HP:6001013Mechanic's hands
HP:0001658Myocardial infarction
HP:0012819Myocarditis
HP:0001701Pericarditis
HP:0025555Periungual teleangiectasia
HP:0001029Poikiloderma
HP:0002092Pulmonary arterial hypertension
HP:0030880Raynaud phenomenon
HP:0011703Sinus tachycardia
HP:0100585Telangiectasia of the skin
HP:0025536V-sign
HP:0002633Vasculitis
Very rare (<4-1%)
HP:0003002Breast carcinoma
HP:0100723Gastrointestinal stroma tumor
HP:0030078Lung adenocarcinoma
HP:0002665Lymphoma
HP:0100630Neoplasia of the nasopharynx
HP:0002664Neoplasm
HP:0100526Neoplasm of the lung
HP:0100615Ovarian neoplasm
HP:0010765Palmar hyperkeratosis
HP:0012490Panniculitis

Run the differential on the 8 obligate / very frequent terms

Annotation source: 32644343[PMID]_31279808[PMID]_29550929[PMID]_40535138 [PMID]_37153943[PMID]_42074677[PMID]_38918941[PMID]_34447769[PMID]

7

Sources for this card